Nucleate Bio Inc

What it reported doing in 2025

See schedule oactivator program - the goal of the nucleate "activator" program is to provide a rigorous and comprehensive educational experience to future biotech entrepreneurs. Our core curriculum consists of bi-weekly workshops held throughout the spring, and culminates in a final pitch event where teams showcase their companies to a large audience of industry stakeholders.the workshops, created in collaboration with our world-class advisors, are structured to address critical aspects of early-stage life science company formation. Together, they are designed to provide a roadmap for translating and commercializing early-stage technology concepts.each workshop consists of three parts:1) pre-work - teams prepare slides and discussion topics ahead of each workshop, which are circulated to workshop experts in advance. At the end of the program, these slides will form the building blocks of their final 10-15 minute polished pitch deck.2) hands-on feedback - during the 2-hour workshops, teams are paired with experts relevant to their targeted market and/or technology who provide feedback on the materials presented by the teams.3) post-work - after each workshop, teams integrate expert feedback and provide an on topic, one paragraph written summary outlining what was learned and what questions are still outstandin. The post-work summary from each workshop will function as a building block for the final business plan.by the end of the program, teams will leave with a polished pitch deck, written business plan, fundraising strategy, and a network of relevant industry advisors and mentors. This year, our curriculum will be managed and administered through the eduflow platform to create an integrated, uniform, and seamless experience for participants

Financial Efficiency

• Mission deployment rate: 96.4%; rating input score 96
• Program expense ratio: 85.2%; rating input score 85
• Fundraising efficiency: Limited

Transparency & Controls

• Consistency checks: 100%; rating input score 100; 63rd percentile among comparable filings
• Pay-setting controls: Limited
• Foreign activity oversight: 0 of 8 controls in place; rating input score 0
  • Claims monitoring procedures: Fail
  • Requires narrative reports: Fail
  • Conducts field audits: Fail
  • May suspend future funding: Fail
  • Requires financial reports: Fail
  • Conducts site visits: Fail
  • Requires grant agreements: Fail
  • May require repayment: Fail
• Grant itemization coverage: 100%; rating input score 100; 78th percentile among comparable filings
• Major donor itemization: Yes; rating input score 100
• Related-party transparency: Limited

Accountability

• Independent voting board: 100%; rating input score 100; 64th percentile among comparable filings
• Governance controls: 7 of 7 controls in place; rating input score 100
  • Conflict-of-interest policy: Pass
  • Whistleblower policy: Pass
  • Document-retention policy: Pass
  • CEO compensation review process: NotApplicable
  • Other executive compensation review process: NotApplicable
  • Form 990 shared with the board: Pass
  • Board meeting minutes documented: Pass
  • Audit committee oversight: Pass
  • Independent financial-statement audit: Pass

Sustainability

• Operating margin: -13.2%; rating input score 10; 10th percentile among comparable filings
• Total-asset coverage ratio: 0.39; rating input score 19; 19th percentile among comparable filings
• Liabilities to assets ratio: 0.36; rating input score 17; 17th percentile among comparable filings
• Officer compensation ratio: 0%; rating input score 78; 78th percentile among comparable filings

Growth

• Program expense growth: 13% per year; rating input score 100; 66th percentile among comparable filings
• Revenue growth: 27.7% per year; rating input score 100; 89th percentile among comparable filings
• Asset growth: 20.4% per year; rating input score 100; 79th percentile among comparable filings